Annual CFI
-$11.12 M
+$29.28 M+72.49%
September 30, 2022
Summary
- As of February 10, 2025, VIVO annual cash flow from investing activities is -$11.12 million, with the most recent change of +$29.28 million (+72.49%) on September 30, 2022.
- During the last 3 years, VIVO annual CFI has risen by +$37.34 million (+77.06%).
Performance
VIVO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
-$2.23 M
+$3.48 M+60.99%
September 30, 2022
Summary
- As of February 10, 2025, VIVO quarterly cash flow from investing activities is -$2.23 million, with the most recent change of +$3.48 million (+60.99%) on September 30, 2022.
- Over the past year, VIVO quarterly CFI has increased by +$16.76 million (+88.27%).
Performance
VIVO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
-$11.12 M
+$16.76 M+60.13%
September 30, 2022
Summary
- As of February 10, 2025, VIVO TTM cash flow from investing activities is -$11.12 million, with the most recent change of +$16.76 million (+60.13%) on September 30, 2022.
- Over the past year, VIVO TTM CFI has increased by +$29.28 million (+72.49%).
Performance
VIVO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VIVO Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +72.5% | +88.3% | +72.5% |
3 y3 years | +77.1% | -2304.9% | +76.7% |
5 y5 years | -148.8% | -109.1% | +76.7% |
VIVO Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +263.4% | +51.4% | +156.4% | at high | +215.1% |
5 y | 5-year | at high | +391.2% | +555.0% | +2245.2% | at high | +529.9% |
alltime | all time | -309.7% | +500.0% | -128.2% | +2725.6% | -309.7% | +529.9% |
Meridian Bioscience Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | -$11.12 M(-72.5%) | -$2.23 M(-61.0%) | -$11.12 M(-60.1%) |
Jun 2022 | - | -$5.71 M(+288.1%) | -$27.88 M(+4.7%) |
Mar 2022 | - | -$1.47 M(-13.9%) | -$26.62 M(-24.0%) |
Dec 2021 | - | -$1.71 M(-91.0%) | -$35.02 M(-13.3%) |
Sep 2021 | -$40.40 M(-26.0%) | -$18.99 M(+326.5%) | -$40.40 M(+81.7%) |
Jun 2021 | - | -$4.45 M(-54.9%) | -$22.23 M(-68.2%) |
Mar 2021 | - | -$9.87 M(+39.3%) | -$70.01 M(+14.1%) |
Dec 2020 | - | -$7.09 M(+755.8%) | -$61.34 M(+12.4%) |
Sep 2020 | -$54.60 M(+12.7%) | -$828.00 K(-98.4%) | -$54.60 M(+1.7%) |
Jun 2020 | - | -$52.23 M(+4241.4%) | -$53.67 M(+12.1%) |
Mar 2020 | - | -$1.20 M(+253.8%) | -$47.88 M(+0.4%) |
Dec 2019 | - | -$340.00 K(-436.6%) | -$47.68 M(-1.6%) |
Sep 2019 | -$48.45 M(+1053.3%) | $101.00 K(-100.2%) | -$48.45 M(-1.9%) |
Jun 2019 | - | -$46.44 M(+4525.5%) | -$49.41 M(+1089.6%) |
Mar 2019 | - | -$1.00 M(-9.5%) | -$4.15 M(+1.9%) |
Dec 2018 | - | -$1.11 M(+28.8%) | -$4.08 M(-3.0%) |
Sep 2018 | -$4.20 M(-6.0%) | -$861.00 K(-27.0%) | -$4.20 M(-4.6%) |
Jun 2018 | - | -$1.18 M(+27.4%) | -$4.41 M(+1.2%) |
Mar 2018 | - | -$926.00 K(-25.0%) | -$4.35 M(+1.0%) |
Dec 2017 | - | -$1.23 M(+15.9%) | -$4.31 M(-3.5%) |
Sep 2017 | -$4.47 M(-93.3%) | -$1.06 M(-5.7%) | -$4.47 M(-5.3%) |
Jun 2017 | - | -$1.13 M(+28.1%) | -$4.72 M(+1.5%) |
Mar 2017 | - | -$881.00 K(-36.7%) | -$4.65 M(-93.0%) |
Dec 2016 | - | -$1.39 M(+5.7%) | -$66.69 M(0.0%) |
Sep 2016 | -$66.69 M(+1739.4%) | -$1.32 M(+24.1%) | -$66.69 M(+0.5%) |
Jun 2016 | - | -$1.06 M(-98.3%) | -$66.36 M(+1.5%) |
Mar 2016 | - | -$62.92 M(+4420.5%) | -$65.38 M(+1673.3%) |
Dec 2015 | - | -$1.39 M(+41.9%) | -$3.69 M(+1.7%) |
Sep 2015 | -$3.63 M(-48.2%) | -$981.00 K(+1067.9%) | -$3.63 M(-9.2%) |
Jun 2015 | - | -$84.00 K(-93.2%) | -$3.99 M(-24.9%) |
Mar 2015 | - | -$1.23 M(-7.6%) | -$5.31 M(-8.3%) |
Dec 2014 | - | -$1.33 M(-1.2%) | -$5.80 M(-17.2%) |
Sep 2014 | -$7.00 M(+113.7%) | -$1.35 M(-4.1%) | -$7.00 M(+4.2%) |
Jun 2014 | - | -$1.41 M(-18.0%) | -$6.72 M(+10.2%) |
Mar 2014 | - | -$1.71 M(-32.5%) | -$6.10 M(+12.7%) |
Dec 2013 | - | -$2.54 M(+138.4%) | -$5.41 M(+65.1%) |
Sep 2013 | -$3.28 M(-26.1%) | -$1.06 M(+35.5%) | -$3.28 M(+18.8%) |
Jun 2013 | - | -$785.00 K(-23.4%) | -$2.76 M(-11.3%) |
Mar 2013 | - | -$1.02 M(+154.3%) | -$3.11 M(+7.4%) |
Dec 2012 | - | -$403.00 K(-26.1%) | -$2.90 M(-34.7%) |
Sep 2012 | -$4.43 M(-51.5%) | -$545.00 K(-52.1%) | -$4.43 M(-17.3%) |
Jun 2012 | - | -$1.14 M(+40.5%) | -$5.36 M(-19.1%) |
Mar 2012 | - | -$810.00 K(-58.3%) | -$6.63 M(-22.2%) |
Dec 2011 | - | -$1.94 M(+31.8%) | -$8.52 M(-6.9%) |
Sep 2011 | -$9.15 M(-44.0%) | -$1.47 M(-38.8%) | -$9.15 M(-66.8%) |
Jun 2011 | - | -$2.41 M(-10.9%) | -$27.60 M(+49.4%) |
Mar 2011 | - | -$2.70 M(+5.1%) | -$18.48 M(+8.6%) |
Dec 2010 | - | -$2.57 M(-87.1%) | -$17.02 M(+4.2%) |
Sep 2010 | -$16.33 M(+397.9%) | -$19.93 M(-396.6%) | -$16.33 M(-802.8%) |
Jun 2010 | - | $6.72 M(-640.0%) | $2.32 M(-145.6%) |
Mar 2010 | - | -$1.24 M(-33.8%) | -$5.09 M(+2.5%) |
Dec 2009 | - | -$1.88 M(+48.0%) | -$4.97 M(+51.4%) |
Sep 2009 | -$3.28 M(-75.2%) | -$1.27 M(+81.7%) | -$3.28 M(-1.6%) |
Jun 2009 | - | -$699.00 K(-37.5%) | -$3.33 M(-28.2%) |
Mar 2009 | - | -$1.12 M(+479.3%) | -$4.64 M(-39.6%) |
Dec 2008 | - | -$193.00 K(-85.4%) | -$7.69 M(-41.9%) |
Sep 2008 | -$13.23 M(+2886.5%) | -$1.32 M(-34.1%) | -$13.23 M(+2.2%) |
Jun 2008 | - | -$2.01 M(-51.8%) | -$12.95 M(+13.3%) |
Mar 2008 | - | -$4.17 M(-27.4%) | -$11.43 M(+19.7%) |
Dec 2007 | - | -$5.74 M(+450.0%) | -$9.55 M(+2055.8%) |
Sep 2007 | -$443.00 K(-94.9%) | -$1.04 M(+115.5%) | -$443.00 K(-85.3%) |
Jun 2007 | - | -$484.00 K(-78.8%) | -$3.01 M(-26.5%) |
Mar 2007 | - | -$2.29 M(-167.8%) | -$4.09 M(-4.0%) |
Dec 2006 | - | $3.37 M(-193.5%) | -$4.26 M(-50.9%) |
Sep 2006 | -$8.69 M | -$3.61 M(+130.0%) | -$8.69 M(+76.1%) |
Jun 2006 | - | -$1.57 M(-36.2%) | -$4.93 M(+3.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2006 | - | -$2.46 M(+132.8%) | -$4.77 M(-52.5%) |
Dec 2005 | - | -$1.06 M(-813.5%) | -$10.05 M(+4.1%) |
Sep 2005 | -$9.65 M(+217.0%) | $148.00 K(-110.5%) | -$9.65 M(-6.6%) |
Jun 2005 | - | -$1.41 M(-81.8%) | -$10.33 M(+4.8%) |
Mar 2005 | - | -$7.73 M(+1076.7%) | -$9.85 M(+221.8%) |
Dec 2004 | - | -$657.00 K(+22.8%) | -$3.06 M(+0.6%) |
Sep 2004 | -$3.04 M(-6.4%) | -$535.00 K(-42.5%) | -$3.04 M(-1.8%) |
Jun 2004 | - | -$930.00 K(-1.1%) | -$3.10 M(+18.0%) |
Mar 2004 | - | -$940.00 K(+47.3%) | -$2.63 M(-26.9%) |
Dec 2003 | - | -$638.00 K(+8.1%) | -$3.59 M(+10.4%) |
Sep 2003 | -$3.25 M(-22.6%) | -$590.00 K(+29.1%) | -$3.25 M(-27.6%) |
Jun 2003 | - | -$457.00 K(-76.0%) | -$4.49 M(-3.5%) |
Mar 2003 | - | -$1.91 M(+535.0%) | -$4.65 M(+26.5%) |
Dec 2002 | - | -$300.00 K(-83.6%) | -$3.68 M(-12.4%) |
Sep 2002 | -$4.20 M(+119.5%) | -$1.83 M(+194.4%) | -$4.20 M(+43.5%) |
Jun 2002 | - | -$621.00 K(-33.2%) | -$2.93 M(+2.5%) |
Mar 2002 | - | -$929.00 K(+12.9%) | -$2.85 M(+23.8%) |
Dec 2001 | - | -$823.00 K(+48.6%) | -$2.31 M(+20.5%) |
Sep 2001 | -$1.91 M(-80.3%) | -$554.00 K(+0.9%) | -$1.91 M(-81.0%) |
Jun 2001 | - | -$549.00 K(+44.5%) | -$10.08 M(+43.8%) |
Mar 2001 | - | -$380.00 K(-11.8%) | -$7.01 M(-21.0%) |
Dec 2000 | - | -$431.00 K(-95.1%) | -$8.87 M(-8.9%) |
Sep 2000 | -$9.74 M(-45.6%) | -$8.72 M(-445.5%) | -$9.74 M(+1501.3%) |
Jun 2000 | - | $2.52 M(-212.6%) | -$608.00 K(-82.8%) |
Mar 2000 | - | -$2.24 M(+72.4%) | -$3.54 M(+342.6%) |
Dec 1999 | - | -$1.30 M(-417.1%) | -$800.00 K(-95.5%) |
Sep 1999 | -$17.90 M(-437.7%) | $410.00 K(-200.0%) | -$17.90 M(+64.1%) |
Jun 1999 | - | -$410.00 K(-182.0%) | -$10.91 M(-5.1%) |
Mar 1999 | - | $500.00 K(-102.7%) | -$11.50 M(-5.7%) |
Dec 1998 | - | -$18.40 M(-348.6%) | -$12.20 M(-330.2%) |
Sep 1998 | $5.30 M(+307.7%) | $7.40 M(-840.0%) | $5.30 M(-167.1%) |
Jun 1998 | - | -$1.00 M(+400.0%) | -$7.90 M(+2.6%) |
Mar 1998 | - | -$200.00 K(-77.8%) | -$7.70 M(+2.7%) |
Dec 1997 | - | -$900.00 K(-84.5%) | -$7.50 M(-676.9%) |
Sep 1997 | $1.30 M(-105.9%) | -$5.80 M(+625.0%) | $1.30 M(-118.6%) |
Jun 1997 | - | -$800.00 K(<-9900.0%) | -$7.00 M(-48.5%) |
Mar 1997 | - | $0.00(-100.0%) | -$13.60 M(-1.4%) |
Dec 1996 | - | $7.90 M(-156.0%) | -$13.80 M(-37.0%) |
Sep 1996 | -$21.90 M(+776.0%) | -$14.10 M(+90.5%) | -$21.90 M(+160.7%) |
Jun 1996 | - | -$7.40 M(+3600.0%) | -$8.40 M(+394.1%) |
Mar 1996 | - | -$200.00 K(0.0%) | -$1.70 M(-26.1%) |
Dec 1995 | - | -$200.00 K(-66.7%) | -$2.30 M(-8.0%) |
Sep 1995 | -$2.50 M(-43.2%) | -$600.00 K(-14.3%) | -$2.50 M(+8.7%) |
Jun 1995 | - | -$700.00 K(-12.5%) | -$2.30 M(-4.2%) |
Mar 1995 | - | -$800.00 K(+100.0%) | -$2.40 M(-47.8%) |
Dec 1994 | - | -$400.00 K(0.0%) | -$4.60 M(+4.5%) |
Sep 1994 | -$4.40 M(+2.3%) | -$400.00 K(-50.0%) | -$4.40 M(-2.2%) |
Jun 1994 | - | -$800.00 K(-73.3%) | -$4.50 M(-37.5%) |
Mar 1994 | - | -$3.00 M(+1400.0%) | -$7.20 M(+60.0%) |
Dec 1993 | - | -$200.00 K(-60.0%) | -$4.50 M(+4.7%) |
Sep 1993 | -$4.30 M(+115.0%) | -$500.00 K(-85.7%) | -$4.30 M(+13.2%) |
Jun 1993 | - | -$3.50 M(+1066.7%) | -$3.80 M(+245.5%) |
Mar 1993 | - | -$300.00 K(<-9900.0%) | -$1.10 M(-8.3%) |
Dec 1992 | - | $0.00(0.0%) | -$1.20 M(-40.0%) |
Sep 1992 | -$2.00 M(+33.3%) | $0.00(-100.0%) | -$2.00 M(-23.1%) |
Jun 1992 | - | -$800.00 K(+100.0%) | -$2.60 M(0.0%) |
Mar 1992 | - | -$400.00 K(-50.0%) | -$2.60 M(+18.2%) |
Dec 1991 | - | -$800.00 K(+33.3%) | -$2.20 M(+46.7%) |
Sep 1991 | -$1.50 M(-31.8%) | -$600.00 K(-25.0%) | -$1.50 M(+66.7%) |
Jun 1991 | - | -$800.00 K(<-9900.0%) | -$900.00 K(+800.0%) |
Mar 1991 | - | $0.00(-100.0%) | -$100.00 K(-95.5%) |
Dec 1990 | - | -$100.00 K(<-9900.0%) | -$2.20 M(0.0%) |
Sep 1990 | -$2.20 M | $0.00(0.0%) | -$2.20 M(0.0%) |
Jun 1990 | - | $0.00(-100.0%) | -$2.20 M(0.0%) |
Mar 1990 | - | -$2.10 M(+2000.0%) | -$2.20 M(+2100.0%) |
Dec 1989 | - | -$100.00 K | -$100.00 K |
FAQ
- What is Meridian Bioscience annual cash flow from investing activities?
- What is the all time high annual CFI for Meridian Bioscience?
- What is Meridian Bioscience annual CFI year-on-year change?
- What is Meridian Bioscience quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Meridian Bioscience?
- What is Meridian Bioscience quarterly CFI year-on-year change?
- What is Meridian Bioscience TTM cash flow from investing activities?
- What is the all time high TTM CFI for Meridian Bioscience?
- What is Meridian Bioscience TTM CFI year-on-year change?
What is Meridian Bioscience annual cash flow from investing activities?
The current annual CFI of VIVO is -$11.12 M
What is the all time high annual CFI for Meridian Bioscience?
Meridian Bioscience all-time high annual cash flow from investing activities is $5.30 M
What is Meridian Bioscience annual CFI year-on-year change?
Over the past year, VIVO annual cash flow from investing activities has changed by +$29.28 M (+72.49%)
What is Meridian Bioscience quarterly cash flow from investing activities?
The current quarterly CFI of VIVO is -$2.23 M
What is the all time high quarterly CFI for Meridian Bioscience?
Meridian Bioscience all-time high quarterly cash flow from investing activities is $7.90 M
What is Meridian Bioscience quarterly CFI year-on-year change?
Over the past year, VIVO quarterly cash flow from investing activities has changed by +$16.76 M (+88.27%)
What is Meridian Bioscience TTM cash flow from investing activities?
The current TTM CFI of VIVO is -$11.12 M
What is the all time high TTM CFI for Meridian Bioscience?
Meridian Bioscience all-time high TTM cash flow from investing activities is $5.30 M
What is Meridian Bioscience TTM CFI year-on-year change?
Over the past year, VIVO TTM cash flow from investing activities has changed by +$29.28 M (+72.49%)